A study in Lancet Digital Health reports that a previously validated, high performing AI model committed troublesome errors when confronted with atypical anatomy.

The first-in-man study, completed by a team of cardiologists in China, included 10 patients presenting with HFpEF. 

Steven E. Nissen, MD, chief academic officer of the Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute at the Cleveland Clinic, was the lead author on the Apollo Trial, a late-breaking ACC.22 study evaluating the effectiveness of an mRNA drug to suppress lipoprotein(a).

The new international consensus document gives detailed recommendations on when to offer genetic testing for patients and their family members. 

ACR and others have submitted a formal national coverage determination request, asking the agency to address payment gaps for virtual colonoscopies. 

The mandatory bundled payment initiative was slated to kick off Jan. 1, 2023, following numerous delays, but will now launch on a to-be-determined date.

This marks the ninth 510(k) clearance for the company, which has offices in Israel and New York, and second in the past 10 days. 

A team of researchers have developed a new tool that benchmarks brain development and growth based on over 120,000 MRI scans.

An updated look at patients treated with Medtronic's renal denervation system was presented at ACC.22 and simultaneously published in The Lancet. 

In a new study published in the AJR, pre-scan same day eGFR testing revealed that out of 10,256 patients who had these labs, only 1.4% displayed levels below the recommended cutoff.